| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Arch Capital Trades Above 50-Day SMA: Time to Buy ACGL Stock? | ||
| Fr | Reasons to Hold AngioDynamics Stock in Your Portfolio for Now | ||
| Fr | Symbotic Set to Report Q4 Earnings: Buy, Sell or Hold the Stock? | ||
| Fr | Broadcom Unveils Quantum-Safe Switch: What's Ahead for the Stock? | ||
| Fr | Mission Produce Slips Below 200-Day SMA: Growth Ahead or Caution? | ||
| Fr | Copart Q1 Earnings Surpass Expectations, Revenues Increase Y/Y | ||
| Fr | Can CCL Maintain Record Pricing Across Both North America and Europe? | ||
| Fr | MasTec Stock Down 8% Post Q3 Earnings: Should You Buy the Dip or Fold? | ||
| Fr | PANW vs. CSCO: Which Cybersecurity Stock Should You Buy Right Now? | ||
| Fr | Roblox Loses Almost a Third of Value in a Month: Smart Time to Enter? | ||
| Fr | Is Credo Technology's Strong Cash Position a Competitive Advantage? | ||
| Fr | CNA Stock Trading at a Discount to Industry at 1.11X: Time to Buy? | ||
| Fr | SemRush Buy to Aid Adobe's AI Expertise: What's Ahead for the Stock? | ||
| Fr | NTLA Declines 67% in a Month: Should You Buy, Sell or Hold the Stock? | ||
| Fr | How ExxonMobil's Integrated Business Model Supports Dividend Growth | ||
| Fr | ET Stock Trading at a Discount to Industry at 8.96X: How to Play? | ||
| Fr | AZN Wins FDA Nod for Expanded Use of Rare Disease Drug, Koselugo | ||
| Fr | NVS Ups Sales Projections as Key Drugs and Collaborations Fuel Growth | ||
| Fr | WDAY Set to Report Q3 Results: Will Revenue Growth Boost Earnings? | ||
| Fr | Intuit Q1 Earnings Surpass Estimates, Online Ecosystem Revenues Surge | ||
| Fr | ITRI Boosts Resiliency Solutions Portfolio With $525M Locusview Buyout | ||
| Fr | EPD to Generate Additional Cash Flows From $5B Project Backlog | ||
| Fr | SERV Stock Dips 17% Post Q3 Earnings: Is the Worst Already Priced In? | ||
| Fr | Opendoor Stock Trades at a Discount: Opportunity or Value Trap? | ||
| Fr | Give Oil a Miss, Focus on Natural Gas Stocks: WMB, AR, CRK |